Jasper Therapeutics Correlations
| JSPR Stock | USD 3.13 0.14 4.28% |
The current 90-days correlation between Jasper Therapeutics and Werewolf Therapeutics is 0.22 (i.e., Modest diversification). The correlation of Jasper Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Jasper Therapeutics Correlation With Market
Weak diversification
The correlation between Jasper Therapeutics and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Jasper Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Moving against Jasper Stock
| 0.6 | AMLX | Amylyx Pharmaceuticals | PairCorr |
| 0.56 | PKX | POSCO Holdings | PairCorr |
| 0.45 | VRDN | Viridian Therapeutics | PairCorr |
| 0.42 | PTAIF | PT Astra International Earnings Call This Week | PairCorr |
| 0.4 | PUTKY | United Tractors Tbk | PairCorr |
| 0.39 | MRVI | Maravai Lifesciences | PairCorr |
| 0.31 | VTYX | Ventyx Biosciences | PairCorr |
| 0.31 | PTAIY | Astra International Tbk Earnings Call This Week | PairCorr |
| 0.52 | JNJ | Johnson Johnson | PairCorr |
| 0.51 | DD | Dupont De Nemours Earnings Call This Week | PairCorr |
| 0.45 | CVX | Chevron Corp Earnings Call This Week | PairCorr |
| 0.36 | BA | Boeing Earnings Call This Week | PairCorr |
| 0.35 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
Related Correlations Analysis
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | EFTR | ||
| 0.0 | -0.35 | 0.1 | 0.56 | 0.3 | 0.17 | ENSC | ||
| 0.0 | -0.35 | 0.14 | -0.46 | -0.6 | -0.06 | HOWL | ||
| 0.0 | 0.1 | 0.14 | 0.45 | -0.4 | -0.39 | PALI | ||
| 0.0 | 0.56 | -0.46 | 0.45 | 0.02 | -0.16 | RNAZ | ||
| 0.0 | 0.3 | -0.6 | -0.4 | 0.02 | 0.57 | SPRB | ||
| 0.0 | 0.17 | -0.06 | -0.39 | -0.16 | 0.57 | UNCY | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Jasper Stock performing well and Jasper Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Jasper Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| EFTR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ENSC | 5.44 | 0.42 | 0.11 | 0.42 | 5.62 | 9.35 | 109.72 | |||
| HOWL | 4.34 | 0.24 | 0.14 | 0.31 | 4.10 | 12.12 | 35.53 | |||
| PALI | 4.51 | 0.58 | 0.14 | 0.64 | 3.97 | 8.33 | 36.14 | |||
| RNAZ | 6.16 | 0.41 | 0.08 | 0.49 | 6.69 | 14.91 | 59.97 | |||
| SPRB | 4.50 | (2.22) | 0.00 | (1.08) | 0.00 | 7.14 | 65.47 | |||
| UNCY | 5.56 | (0.21) | (0.01) | 0.07 | 9.89 | 14.48 | 60.25 |
Jasper Therapeutics Corporate Management
| Kimberly Baxter | VP Quality | Profile | |
| Luca Noto | Senior Operations | Profile | |
| Carol Zoltowski | VP Quality | Profile | |
| Jeetinder MBA | Chief Officer | Profile |